Tirzepatide (Mounjaro)
تيرزيباتيد (Mounjaro)
Last updated: Reviewed by Dr. Ahmad Arafat Hasan
Weekly dual GLP-1/GIP agonist, currently the most potent agent for obesity (Zepbound) and type 2 diabetes.
Overview
Tirzepatide (Mounjaro) (Arabic: تيرزيباتيد (Mounjaro))
Weekly dual GLP-1/GIP agonist, currently the most potent agent for obesity (Zepbound) and type 2 diabetes.
This term is classified as: medication.
This explanation is for general educational purposes only and is not a substitute for medical advice from a qualified physician. If you experience symptoms or have concerns, please consult your healthcare provider immediately.
Frequently asked questions
What is Tirzepatide (Mounjaro) in Arabic?
Tirzepatide (Mounjaro) in Arabic is تيرزيباتيد (Mounjaro).
What does تيرزيباتيد (Mounjaro) mean in English?
تيرزيباتيد (Mounjaro) means Tirzepatide (Mounjaro) in English. Weekly dual GLP-1/GIP agonist, currently the most potent agent for obesity (Zepbound) and type 2 diabetes.
Medical authoring & review
Last reviewed: 20 October 2026Last updated: 13 September 2026